Sign in
CompletedPhase 1

Robotic ankle device for walking in children with cerebral palsy

Tests a robotic ankle device in children with cerebral palsy.

Key facts

Who runs it
Northern Arizona University
Where
Minneapolis, United StatesSee the site
Trial code
Registry title
Augmenting Ankle Plantarflexor Function in Cerebral Palsy
Status
Completed
Phase
Phase 1
People taking part
36 people enrolled
Started
1 Feb 2023
Ended
25 Sept 2026
Type of study
Interventional, 6 groups
Treatments tested
  • Biomotum Spark: Robotic ankle assistance
  • Biomotum Spark: Robotic ankle resistance
  • Standard gait training
  • Ankle foot orthosis
  • Standard physical therapy
  • Standard walking
Record updated
16 November 2026

Who can take part

AI summary

From the trial's eligibility criteria. Machine-read from the registry text on this page, so it can be wrong. The registry text below and the trial team decide who can take part.

The trial is looking for children and young people with cerebral palsy (CP) who can walk and whose walking is affected by a problem at the ankle.

Age
8 to 21 years old.
Sex
All sexes can join.
Disease stage
Diagnosis of CP with an abnormal walking pattern caused by the ankle. Must walk at least 30 feet, with or without a walking aid (GMFCS Level I-III). Must have at least 20° of passive ankle movement pointing the foot down (plantar-flexion).
Earlier treatment
No surgery within 6 months before taking part.

Main reasons for not taking part

  • Other treatment at the same time, beyond what the study gives.
  • A condition other than CP that would make taking part unsafe.
  • Surgery within 6 months of taking part.
  • Not able to understand and follow simple directions.

The registry criteria, word for word

Show all 6 criteriaShow less

Who can take part

  • Ages between 8 and 21 years old, inclusive. Diagnosis of CP and a pathological gait pattern caused by ankle dysfunction
  • Able to understand and follow simple directions (based on parent report, if needed) and walk at least 30 feet with or without a walking aid (Gross Motor Function Classification System (GMFCS) Level I-III)
  • At least 20° of passive plantar-flexion range of motion

Who cannot take part

  • Concurrent treatment other than those assigned during the study
  • Surgical intervention within 6 months of participation
  • A condition other than CP that would affect safe participation

Where in United States

  • Gillette Children's Specialty HealthcareMinneapolis, United States

About the trial

What the trial wants to find out

The first specific aim is to quantify improvement in ankle muscle function and functional mobility following targeted ankle resistance gait training in ambulatory children with cerebral palsy (CP). The primary hypothesis for the first aim is that targeted ankle resistance training will produce larger improvements in lower-extremity motor control, gait mechanics, and clinical measures of mobility assessed four- and twelve-weeks post intervention compared to standard physical therapy and standard gait training. The second specific aim is to determine the efficacy of adaptive ankle assistance to improve capacity and performance during sustained, high-intensity, and challenging tasks in ambulatory children with CP. The primary hypothesis for the second aim is that adaptive ankle assistance will result in significantly greater capacity and performance during the six-minute-walk-test and graded treadmill and stair stepping protocols compared to walking with ankle foot orthoses and walking with just shoes.

The 6 groups in the trial

  • Device resisted gait training (treatment)Treatment being tested

    We will conduct a randomized controlled trial (treatment vs. control) to compare functional outcomes following bilateral targeted ankle resistance training (2 visits/week for 12 weeks) vs. dose-matched standard functional gait training.

    Treatment: Biomotum Spark: Robotic ankle resistance

  • Standard gait training (control)Treatment being tested

    We will conduct a randomized controlled trial (treatment vs. control) to compare functional outcomes following bilateral targeted ankle resistance training (2 visits/week for 12 weeks) vs. dose-matched standard functional gait training.

    Treatment: Standard gait training

  • Comparison to Standard PT (within subjects control)Treatment being tested

    We will use a within-subject repeated measures design to compare both gait training groups to matched standard physical therapy.

    Treatment: Standard physical therapy

  • Device assisted ambulationTreatment being tested

    We will compare task capacity and performance with adaptive ankle assistance vs. standard ankle foot orthoses and vs. shod (no ankle aid).

    Treatment: Biomotum Spark: Robotic ankle assistance

  • Passive brace assisted ambulationTreatment being tested

    We will compare task capacity and performance with adaptive ankle assistance vs. standard ankle foot orthoses and vs. shod (no ankle aid).

    Treatment: Ankle foot orthosis

  • No ankle aid ambulationTreatment being tested

    We will compare task capacity and performance with adaptive ankle assistance vs. standard ankle foot orthoses and vs. shod (no ankle aid).

    Treatment: Standard walking

Data and sources

Registry record
Listed on ClinicalTrials.gov.How to verify a trial in the registry
Official title
Augmenting Ankle Plantarflexor Function and Walking Capacity in Children With Cerebral Palsy
Plain-language title
Robotic ankle device for walking in children with cerebral palsyGenerated from the registry record. The registry title is the official one.
AI summary
From the trial's eligibility criteria. Read by machine on 14 November 2026.
Record updated
16 November 2026